Neoplas Med, a Greifswald, Germany-based based mostly medical expertise firm, acquired $18M in funding.
Niterra Ventures Firm made the funding.
The corporate intends to make use of the funds to speed up worldwide growth and expertise platform growth for treating contaminated and persistent wounds.
Led by CEO Ulrike Sailer, Neoplas Med is advancing the probabilities of argon chilly plasma jet remedy in scientific use and is thus working to successfully and sustainably enhance the standard of life of individuals with acute and persistent wounds. The corporate has created the argon chilly plasma jet, kINPen® MED, a ‘plasma pen’ that directs a exact plasma jet onto wounds and considerably accelerates wound therapeutic. Neoplas Med makes use of the inert fuel argon for this speedy remedy, treating each contaminated and persistent wounds. With its ‘plasma pen,’ it’s a producer of chilly plasma merchandise in Europe that’s European Medical Machine Regulation (MDR) licensed.
FinSMEs
25/11/2024
